SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-026602
Filing Date
2022-09-23
Accepted
2022-09-23 06:15:12
Documents
14
Period of Report
2022-09-19
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43078
2 ex3-1.htm EX-3.1 15825
3 ex99-1.htm EX-99.1 12555
  Complete submission text file 0001493152-22-026602.txt   250819

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cytr-20220919.xsd EX-101.SCH 3218
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cytr-20220919_lab.xml EX-101.LAB 34240
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cytr-20220919_pre.xml EX-101.PRE 22353
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3686
Mailing Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049
Business Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 310-826-5648
CYTRX CORP (Filer) CIK: 0000799698 (see all company filings)

IRS No.: 581642750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15327 | Film No.: 221260569
SIC: 2836 Biological Products, (No Diagnostic Substances)